Arkolith/Insider Trading/IMVT/Form 4

Van Tuyl Christopher

Chief Legal OfficerImmunovant, Inc. (IMVT) · full profile →Form 4 · filed Mar 20, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$72K
Net Open-Market Flow
-$72K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 18, 2026Sell(S)3K$24.97$72K147K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001764013-26-000015) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML